About the Webinar
Presented at Oxford Global’s Spatial Biology US: Online conference, this webinar highlights the power of spatial genomics utilizing the NanoString® GeoMx™ Digital Spatial Profiler, as well as Azenta Life Sciences' use of the platform in performing reproducible, high-quality, and high-plex protein profiling of gastric cancer and high-throughput RNA profiling of urothelial carcinoma. Additionally, Dr. Corney elaborates on the differences between traditional transcriptomic profiling and the validation work performed at Azenta Life Sciences.
What You'll Learn
-
The GeoMx platform and Azenta Life Sciences' digital spatial profiling (DSP) workflow leveraging the platform
-
Azenta’s use of Cancer Transcriptome Atlas (CTA) panel for the generation of over 100,000 gene expression data points from a single FFPE section in urothelial carcinoma research
-
How Azenta identified patterns of proteomic expression signatures in gastric cancer with surgical resection samples
-
Additional resources to learn more about spatial genomics, including DSP
About the Presenters
David Corney, Ph.D.
Principal Scientist, Process Development
Azenta Life Sciences
Dr. David Corney is a principal scientist within the Process Development team at Azenta Life Sciences. For the past five years, he has focused on evaluating emerging technologies within the genomics portfolio at Azenta where he led the development and commercialization of Azenta's PacBio® long-read sequencing, 10x Genomics® single-cell sequencing, and digital spatial profiling services.
Dr. Corney earned his Ph.D. in environmental toxicology from Cornell University and performed postdoctoral studies at Stanford University and Princeton University, employing various genomic approaches to study cancer stem cells.
